Kolczewski, P.; Parafiniuk, M.; Zawodny, P.; Haddad, R.; Nalewczyńska, A.; Kolasa, A.K.; Wiszniewska, B.; Menkes, S.; Bader, A.; Stabile, G.;
et al. Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity. Pharmaceuticals 2022, 15, 1571.
https://doi.org/10.3390/ph15121571
AMA Style
Kolczewski P, Parafiniuk M, Zawodny P, Haddad R, Nalewczyńska A, Kolasa AK, Wiszniewska B, Menkes S, Bader A, Stabile G,
et al. Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity. Pharmaceuticals. 2022; 15(12):1571.
https://doi.org/10.3390/ph15121571
Chicago/Turabian Style
Kolczewski, Piotr, Mirosław Parafiniuk, Piotr Zawodny, Rashad Haddad, Agnieszka Nalewczyńska, Agnieszka Kinga Kolasa, Barbara Wiszniewska, Sophie Menkes, Alexander Bader, Giorgio Stabile,
and et al. 2022. "Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity" Pharmaceuticals 15, no. 12: 1571.
https://doi.org/10.3390/ph15121571
APA Style
Kolczewski, P., Parafiniuk, M., Zawodny, P., Haddad, R., Nalewczyńska, A., Kolasa, A. K., Wiszniewska, B., Menkes, S., Bader, A., Stabile, G., & Zerbinati, N.
(2022). Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity. Pharmaceuticals, 15(12), 1571.
https://doi.org/10.3390/ph15121571